Clinical Trial Update: 4R for Guideline Indicated BRCA Testing of Breast Center Patients

View source ↗

Summary

A completed Northwestern University clinical trial evaluated guideline-indicated BRCA testing in breast center patients with newly diagnosed breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Northwestern University | Conditions: Newly Diagnosed Carcinoma of Breast, Genetic Predisposition to Disease | Status: COMPLETED